Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Chloride Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101817783B details a high-yield synthesis of Tolvaptan intermediates via optimized acid chloride activation, offering significant cost reduction in API manufacturing.
Patent CN111763222B reveals a green route for edoxaban free base. Eliminate Pd catalysts and genotoxic impurities for cost-effective API manufacturing.